Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Planet Ventures Inc. Announces Engagement of PRmediaNow Inc., Investor Brand Network and Appointment of Strategic Advisor
-
American Pacific Mining and ICG Silver & Gold Complete Plan of Arrangement for the Sale of the Tuscarora District
-
Divine Mercy University launches School of Spiritual Direction With "Preparing Our Hearts" Foundational Courses
-
VERSABANK'S 2026 ANNUAL MEETING TO BE HELD APRIL 8, 2026 IN LONDON, ONTARIO - MEETING WILL ALSO BE LIVE-STREAMED
-
O'Fallon Township High School Partners with Turnitin to Bring Transparency to Student Writing in the Age of AI
-
ZINFI Technologies Once Again Named a "Leader" in G2 Grid® Report for Partner Relationship Management (PRM), Spring 2026
-
CMG Announces the Acquisition of Rose Subsurface Assessment
-
Who is the Top Money Manager in North Texas? Fisher Investments Earns #1 from "Dallas Business Journal"
-
Maximo Completes 100 MW of Robotic Solar Installation
-
Westhaven Engages San Diego Torrey Hills Capital for Investor Relations
-
KNOT Offshore Partners LP Earnings Release—interim Results for the Period Ended December 31, 2025
-
GridCARE and National Grid Collaborate to Unlock Grid Capacity for Infrastructure
-
Middleby Appoints Brittany Cerwin as Chief Financial Officer
-
Pacific Defense Launches Next-Generation AI-Enabled Digital Signal Processor for Next-Generation Mission Systems
-
EvON Medics Data Demonstrates Digital Olfactory Therapy Reverses Gray Matter Loss in Key Alzheimer's Brain Regions and Significantly Improves Cognition
-
American Express Unveils New Graphite™ Business Cash Unlimited Card, Rewarding Business Owners with Unlimited 2% Cash Back
-
Phillips 66 and Kinder Morgan, Inc. Announce Extension of Second Open Season for Remaining Western Gateway Capacity
-
Deloitte: From Subscribers to Superfans: Fan Engagement Shapes the Next Phase of Media and Entertainment Growth
-
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
-
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
-
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
-
SSR Mining Provides Update on Çöpler Mine Sale
-
Cognyte Wins ~$5M Contract with Tier-1 US Law Enforcement Agency to Power Mission-Critical Investigations
-
Zipments Launches Embedded Trade Tools to Power the Next Generation of Logistics Providers
-
MITER Brands Launches New Sunrise Collection™ Brand
-
Koryx Copper Announces Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia
-
ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems
-
Creator TV® and Convergence Announce Partnership to Bring Creator-Led Programming to Television
-
Pelican Announces Global Partnership with Renowned Explorer and Photographer Chris Burkard
-
Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City
-
CentralReach Introduces Agentic Layer to Automate and Accelerate Revenue Cycle Operations for Autism and IDD Care
-
Guidehouse Secures All Six Lots on UK Government's £18B TS4 Framework
-
NexGold Initiates 30,000-Metre Infill Drill Program at the Goldboro Gold Project in Nova Scotia
-
Garmin Ltd. schedules first quarter 2026 earnings call
-
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
-
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
-
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
-
Dr. Bob Akmens & BASports.com Capture 7th Las Vegas MLB Exhibition Season Title in 9 Years
-
Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval
-
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
-
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
-
Winnebago Industries Reports Second Quarter Fiscal 2026 Results
-
Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026
-
Notch Raises $30 Million to Bring Production-Ready AI Agents to Regulated Industries
-
Energous Wireless Power Solutions Reports Fiscal Year 2025 Results
-
Verano to Report First Quarter 2026 Financial Results on April 30, 2026
-
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
-
Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic
-
NOTICE TO THE ANNUAL GENERAL MEETING OF TULIKIVI CORPORATION 2026
-
ParkerVision Completes Appeal Briefing

